Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Angiotensin Converting Enzyme Inhibitor [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
LISINOPRIL 36,869 4,382 11.9% 13,362 3,353 61.5 yrs 51.9%
RAMIPRIL 33,063 3,786 11.5% 17,747 4,640 65.4 yrs 53.1%
ENALAPRIL 7,730 711 9.2% 3,919 779 63.5 yrs 49.3%
QUINAPRIL 1,839 51 2.8% 830 105 75.0 yrs 91.1%
BENAZEPRIL 1,329 198 14.9% 508 111 63.0 yrs 53.3%
PERINDOPRIL ERBUMINE 1,200 97 8.1% 621 103 65.1 yrs 58.1%
CAPTOPRIL 1,126 108 9.6% 615 192 56.1 yrs 60.9%
TRANDOLAPRIL 617 48 7.8% 318 47 65.0 yrs 46.0%
FOSINOPRIL 461 36 7.8% 219 50 66.1 yrs 41.5%
ENALAPRILAT 63 3 4.8% 19 2 62.7 yrs 53.8%

Head-to-Head Comparisons

LISINOPRIL vs RAMIPRIL LISINOPRIL vs ENALAPRIL LISINOPRIL vs QUINAPRIL LISINOPRIL vs BENAZEPRIL RAMIPRIL vs ENALAPRIL RAMIPRIL vs QUINAPRIL RAMIPRIL vs BENAZEPRIL ENALAPRIL vs QUINAPRIL ENALAPRIL vs BENAZEPRIL QUINAPRIL vs BENAZEPRIL
← Back to Angiotensin Converting Enzyme Inhibitor [EPC] Class side effects →